VTH-202

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVTH-202
Drug Alias NameOncoFluVeconcolytic influenza virus therapy expressing NS1 (Vacthera BioTech)VTH-202
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVacthera BioTech GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVacthera BioTech GmbH
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A